Close Menu
iM.NewsiM.News

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Microplastics Generate Harmful Radicals in Water, Study Finds

    November 21, 2026

    Waymo Recalls Robotaxis After Freeway Lane Incidents

    November 21, 2026

    New Method Could Detect Quantum Superposition of Time

    November 21, 2026
    Facebook X (Twitter) Instagram
    iM.NewsiM.News
    Subscribe
    • Home
    • Lifestyle

      Microplastics Generate Harmful Radicals in Water, Study Finds

      November 21, 2026

      Safety fears rise over Black Friday liquid BBL deals

      November 21, 2026

      Richard Hammond on Divorce, Speeding, and Life After Top Gear

      November 21, 2026

      Northern Ireland Doctors Strike Ends, New Walkout Planned

      November 21, 2026

      Vienna’s Culinary Identity: A Borderless European Legacy

      November 21, 2026
    • Relations

      USDA and FBI Systems Breached Amid US Tech Outages

      November 21, 2026

      Zelensky defends Crimean Bridge strikes as UK minister visits Kyiv

      November 21, 2026

      UK-EU Trade and Youth Deals Signed as Rejoining Talks Loom

      November 21, 2026

      UN AI Weapons Talks Stall, Extend Deadline to 2028

      November 21, 2026

      Zelensky Calls Putin a Killer After Trump’s ‘Friend’ Comment

      November 21, 2026
    • Technology

      Waymo Recalls Robotaxis After Freeway Lane Incidents

      November 21, 2026

      Xiaomi 18 Pro Review: Dual Screens and Flagship Cameras

      November 21, 2026

      AI Model Compresses 1GB Wikipedia to 105MB

      November 21, 2026

      ESA Hera Probe Arrives at Asteroids From NASA DART Test

      November 21, 2026

      Anthropic Shares Slide as Tech Sell-Off Deepens

      November 21, 2026
    • Travel & Tourism

      Accor Shareholder Pushes to Oust CEO After Ennismore Deal

      November 21, 2026

      TAP Air Portugal Adds Nonstop Porto Service from Washington Dulles

      November 20, 2026

      Oil Spills Threaten UAE and Oman Beaches Amid Hormuz Conflict

      November 20, 2026

      Aer Lingus to Retrofit A330 Fleet with Premium Economy and New Business Class

      November 20, 2026

      Sabre Targets AI Travel Bookings With New Connector

      November 20, 2026
    • Get in Touch
    iM.NewsiM.News
    Home»Lifestyle»Health»New Injection CBL-514 Destroys Abdominal Fat in Early Trials
    Health

    New Injection CBL-514 Destroys Abdominal Fat in Early Trials

    im.newsBy im.newsOctober 12, 2026No Comments4 Mins Read17 Views
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    New Injection CBL-514 Destroys Abdominal Fat in Early Trials
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    An experimental injection known as CBL-514 has demonstrated the ability to trigger fat cells to self-destruct, leading to significant reductions in dangerous abdominal fat during early human trials. The findings were presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, by researchers from the University of Alabama at Birmingham and Caliway Biopharmaceuticals.

    Unlike traditional weight loss medications that primarily reduce the amount of fat stored within existing cells, CBL-514 targets adipocytes directly. The drug induces apoptosis, a natural biological process that causes cells to break down and die. This mechanism allows the treatment to reduce both subcutaneous fat, which sits beneath the skin, and visceral fat, which surrounds internal organs like the liver and intestines.

    Clinical Results Show Significant Fat Loss

    Researchers analyzed data from two phase 2 clinical trials, designated CBL-0204 and CBL-0205, to measure the drug’s impact on visceral abdominal fat. The studies involved participants with a body mass index (BMI) between 22 and 30 kg/m2. Patients received injections into the lower abdomen every three weeks for up to 12 weeks, with doses reaching up to 600 mg. Treatment continued until the fat layer fell below a specified thickness threshold.

    Magnetic resonance imaging (MRI) scans were used to measure changes in fat volume before treatment and at follow-up intervals. At the eight-week follow-up for subcutaneous fat, 69.6% of participants treated with CBL-514 lost at least 150 mL of fat volume. None of the participants in the placebo group reached this threshold.

    The effects on visceral fat were similarly pronounced. Four weeks after the final injection, participants in the CBL-514 group experienced an average 12.01% reduction in visceral fat volume compared to their baseline measurements. In contrast, the placebo group showed an average increase of 5.68%. This created a 17.69 percentage point difference between the two groups.

    At the later follow-up, conducted eight to 12 weeks after treatment ended, the CBL-514 group maintained an average visceral fat volume 10.45% below baseline. The placebo group had increased by 11.76%, resulting in a 22.21 percentage point difference. These results suggest that the injection’s effects on visceral fat persistence lasted for several weeks after the treatment concluded.

    Potential for Weight Maintenance After Drug Cessation

    Dr. W. Timothy Garvey of the University of Alabama at Birmingham highlighted that these findings raise the possibility that CBL-514 could help patients maintain weight loss after discontinuing popular GLP-1 receptor agonist medications. Drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound have transformed obesity treatment but often lead to weight regain once patients stop taking them.

    Preclinical studies in animal models provided evidence for this potential benefit. When researchers combined CBL-514 with tirzepatide, a medication used for obesity and type 2 diabetes, the animals experienced greater weight loss than those treated with tirzepatide alone. Furthermore, rats that received both medications regained less weight after tirzepatide was discontinued compared to rats treated only with the diabetes drug.

    The researchers hypothesize that eliminating fat cells reduces the body’s capacity to store fat again. With fewer fat cells available, fat may accumulate more slowly after weight loss. Professor Garvey noted that this approach could help patients preserve health improvements associated with weight loss, including better blood pressure, blood sugar, and cholesterol levels.

    While animal studies support the theory that destroying fat cells aids in weight maintenance, Professor Garvey emphasized that this specific benefit has not yet been confirmed in humans. Additional clinical research is required to determine if the effects observed in rats translate to people.

    The drug was generally well tolerated in the trials. Most reported side effects were temporary reactions at the injection site, including pain, swelling, and redness. These reactions were typically mild to moderate, and no serious adverse events were reported. Existing surgical procedures like liposuction primarily remove subcutaneous fat and do not address visceral fat, making CBL-514 a potential non-surgical alternative for targeting both types of abdominal fat.

    Source: ScienceDaily

    Health
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleRussia Adds Drone Training to Public School Curriculum
    Next Article UK Father Denied Daughter Passport Over DNA Test Demand
    im.news

    Related Posts

    Microplastics Generate Harmful Radicals in Water, Study Finds

    November 21, 2026

    Waymo Recalls Robotaxis After Freeway Lane Incidents

    November 21, 2026

    New Method Could Detect Quantum Superposition of Time

    November 21, 2026
    Leave A Reply Cancel Reply

    Latest Posts

    Microplastics Generate Harmful Radicals in Water, Study Finds

    November 21, 20262 Views

    Waymo Recalls Robotaxis After Freeway Lane Incidents

    November 21, 20263 Views

    New Method Could Detect Quantum Superposition of Time

    November 21, 20262 Views

    USDA and FBI Systems Breached Amid US Tech Outages

    November 21, 20263 Views
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025 News Focus 247 Views

    In a stunning development that has sent shockwaves through political and entertainment circles, Attorney General…

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide the daily life news. You find latest trendy news at our portal, from entertainment to economy or politics.

    We're accepting new partnerships right now.

    Email Us: info@im.news

    Facebook X (Twitter) RSS
    Our Picks

    Microplastics Generate Harmful Radicals in Water, Study Finds

    November 21, 2026

    Waymo Recalls Robotaxis After Freeway Lane Incidents

    November 21, 2026

    New Method Could Detect Quantum Superposition of Time

    November 21, 2026
    Most Popular

    Epstein List Phase 1: Full Flight Logs, Client List Released

    February 28, 2025247 Views

    Microsoft Stock Joins Exclusive $4 Trillion Club After Blockbuster Cloud + AI Earnings

    July 31, 2025208 Views

    DOJ & FBI Find No Epstein Client List, Suicide Confirmed

    July 7, 2025165 Views
    © 2026 I'm News. Designed by I'm News.
    • Home
    • Lifestyle
    • Relations
    • Travel & Tourism
    • Technology

    Type above and press Enter to search. Press Esc to cancel.